Rayonier Advanced Materials stock
RYAMNYSERayonier Advanced Materials Inc., Basic MaterialsISIN US75508B1044
27Score 27 out of 100, Weak
Price and trend
28 / 100
Price history
−8.7% in one yearThe chart shows daily closes over 12 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 36% below it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Sharply down: the price has fallen very quickly lately (RSI 28).
The price is 53% below its 52-week high. Largest decline in 12 years: 98% (July 2014 to April 2020).
Chart figures for advanced users
- SMA 50$7.37
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$8.57
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)28
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$5.48
- The lowest closing price of the last twelve months.
- Resistance$11.75
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Rayonier Advanced Materials Inc. belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $370.69M, is number 103 of 106 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $1.47B (down 10.1% year on year) and a loss of $422.5M.
- MEQIRI Score 27 out of 100 (Weak): rank 454 of 461 in Basic Materials, median 57.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Interest barely coveredOperating profit covers interest only 0 times.Stability 25
- Loss-makingLoss of $365.88M over the last 12 months.Fundamentals 31
- Volatile share priceVolatility 73% a year over the last 12 months.Stability 25
The score is held back by capital allocation and profitability.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 26 to 27.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredNo fair value can be calculated for this stock, so the signal follows the valuation grade.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 26 Sep 2026, revenue rose 1.6% on the twelve months before. Revenue has stayed largely stable since 2011.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 8%, operating 1%, net −29%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 2 Mar 2027in 109 days
- Last reported
- 3 Nov 2026EPS reported −$0.13 (expected $0.00)below expectations
Analyst estimates
- Earnings per share
- −$1.45−24.7%
- Revenue
- $1.46B−1.3%
- Earnings per share
- $0.77−11.5%
- Revenue
- $1.5B−5.6%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +4.6%The full-year outlook stays as previously expected: positive free cash flow in 2026, full-year pricing as planned, and a better second half.
“Our full year outlook remains aligned with our prior expectations of generating positive free cash flow in 2026.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 5 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. One insider sold, $17,634 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Palumbo Lisa MSale
7 Aug 2026, Board
- Shares
- 1,931.49
- Price
- $9.13
- Value
- $17,634
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Rayonier Advanced Materials
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 27
- Sector median
- 57
Categories against the sector medianMedian of 461 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Aspen AerogelsASPN $497.94M45
- Plastika KritisPLAKR.AT $461.15M67
- GevoGEVO $460.12M43
- AdvanSixASIX $425.12M42
- Uzin UtzUZU.DE $372.27M57
- H&R GmbH & Co. KGaA2HRA.DE $282.94M61
- MasterflexMZX.DE $152.94M69
- NabaltecNTG.DE $107.75M50
ETFs that hold Rayonier Advanced Materials
Held by 3 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.01% | 0.30% | €4.28B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.01% | 0.30% | €2.22B |
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.01% | 0.39% | €1.49B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Mar 2023)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
